Literature DB >> 12610122

Human immunodeficiency virus type 1 infection and replication in normal human oral keratinocytes.

Xuan Liu1, Junli Zha, Hongying Chen, Junko Nishitani, Paulo Camargo, Steve W Cole, Jerome A Zack.   

Abstract

Recent epidemiologic studies show increasing human immunodeficiency virus type 1 (HIV-1) transmission through oral-genital contact. This paper examines the possibility that normal human oral keratinocytes (NHOKs) might be directly infected by HIV or might convey infectious HIV virions to adjacent leukocytes. PCR analysis of proviral DNA constructs showed that NHOKs can be infected by CXCR4-tropic (NL4-3 and ELI) and dualtropic (89.6) strains of HIV-1 to generate a weak but productive infection. CCR5-tropic strain Ba-L sustained minimal viral replication. Antibody inhibition studies showed that infection by CXCR4-tropic viral strains is mediated by the galactosylceramide receptor and the CXCR4 chemokine coreceptor. Coculture studies showed that infectious HIV-1 virions can also be conveyed from NHOKs to activated peripheral blood lymphocytes, suggesting a potential role of oral epithelial cells in the transmission of HIV infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12610122      PMCID: PMC149546          DOI: 10.1128/jvi.77.6.3470-3476.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding.

Authors:  C D Rizzuto; R Wyatt; N Hernández-Ramos; Y Sun; P D Kwong; W A Hendrickson; J Sodroski
Journal:  Science       Date:  1998-06-19       Impact factor: 47.728

3.  Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone.

Authors:  A Adachi; H E Gendelman; S Koenig; T Folks; R Willey; A Rabson; M A Martin
Journal:  J Virol       Date:  1986-08       Impact factor: 5.103

Review 4.  The macrophage in the persistence and pathogenesis of HIV infection.

Authors:  H E Gendelman; J M Orenstein; L M Baca; B Weiser; H Burger; D C Kalter; M S Meltzer
Journal:  AIDS       Date:  1989-08       Impact factor: 4.177

5.  Human immunodeficiency virus can infect CD4-negative human fibroblastoid cells.

Authors:  M Tateno; F Gonzalez-Scarano; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

6.  Virus isolation from and identification of HTLV-III/LAV-producing cells in brain tissue from a patient with AIDS.

Authors:  S Gartner; P Markovits; D M Markovitz; R F Betts; M Popovic
Journal:  JAMA       Date:  1986-11-07       Impact factor: 56.272

7.  Components of saliva inactivate human immunodeficiency virus.

Authors:  P N Fultz
Journal:  Lancet       Date:  1986-11-22       Impact factor: 79.321

8.  Synthesis of glycolipid analogues that disrupt binding of HIV-1 gp120 to galactosylceramide.

Authors:  K T Weber; D Hammache; J Fantini; B Ganem
Journal:  Bioorg Med Chem Lett       Date:  2000-05-15       Impact factor: 2.823

9.  Subset of DC-SIGN(+) dendritic cells in human blood transmits HIV-1 to T lymphocytes.

Authors:  Anneke Engering; Sandra J Van Vliet; Teunis B H Geijtenbeek; Yvette Van Kooyk
Journal:  Blood       Date:  2002-09-01       Impact factor: 22.113

10.  Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

Authors:  Y Koyanagi; S Miles; R T Mitsuyasu; J E Merrill; H V Vinters; I S Chen
Journal:  Science       Date:  1987-05-15       Impact factor: 47.728

View more
  19 in total

1.  Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages.

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 2.  Human immunodeficiency virus-associated disruption of mucosal barriers and its role in HIV transmission and pathogenesis of HIV/AIDS disease.

Authors:  Sharof Tugizov
Journal:  Tissue Barriers       Date:  2016-03-03

3.  Molecular interactions of human immunodeficiency virus type 1 with primary human oral keratinocytes.

Authors:  Edward A Acheampong; Zahida Parveen; Lois W Muthoga; Vivian Wasmuth-Peroud; Mehrnush Kalayeh; Adnan Bashir; Robert Diecidue; Muhammad Mukhtar; Roger J Pomerantz
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

Review 4.  Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?

Authors:  C W Cutler; R Jotwani
Journal:  Adv Dent Res       Date:  2006-04-01

5.  Human immunodeficiency virus type 1 stimulates the expression and production of secretory leukocyte protease inhibitor (SLPI) in oral epithelial cells: a role for SLPI in innate mucosal immunity.

Authors:  N K Jana; L R Gray; D C Shugars
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

6.  Class II transactivator (CIITA) enhances cytoplasmic processing of HIV-1 Pr55Gag.

Authors:  Kristen A Porter; Lauren N Kelley; Annette George; Jonathan A Harton; Karen M Duus
Journal:  PLoS One       Date:  2010-06-24       Impact factor: 3.240

Review 7.  The mouth: a gateway or a trap for HIV?

Authors:  Daniel Malamud; Sharon M Wahl
Journal:  AIDS       Date:  2010-01-02       Impact factor: 4.177

Review 8.  The oral mucosa immune environment and oral transmission of HIV/SIV.

Authors:  Lianna F Wood; Ann Chahroudi; Hui-Ling Chen; Heather B Jaspan; Donald L Sodora
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

Review 9.  Oral manifestations associated with HIV infection.

Authors:  Mostafa Nokta
Journal:  Curr HIV/AIDS Rep       Date:  2008-02       Impact factor: 5.071

Review 10.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.